Financial Data and Key Metrics Changes - In Q2, net sales decreased by 17.3%, with an organic decline of 16% [26] - Adjusted EBITDA margin was 21.2%, a decrease of 70 basis points year-over-year [51] - Non-GAAP diluted earnings per share fell by 29% to 3.29[51]−ThecompanyexpectsQ3salestodeclinebetween305 million in premium supply chain costs compared to pre-pandemic levels, which are expected to be fully mitigated entering Q3 [55] - The company is focused on achieving 100% cash conversion over a cycle as part of its long-term incentive compensation plan [16] Q&A Session All Questions and Answers Question: Can you elaborate on the reset of the trajectory for e-commerce? - Management indicated that the reset is widespread, affecting various customers who are absorbing capacity built during the pandemic [60][63] Question: What is the outlook for the fourth quarter? - Management expects an uptick in Q4 revenue due to reduced destocking by distributors, but overall demand remains uncertain [66] Question: What are the biggest drivers of the recent demand decline? - The decline is driven by cautious spending behavior across all end markets, particularly in retail and e-commerce [71][72] Question: How is the machine vision segment performing? - The machine vision business is performing well, with growth opportunities in electric vehicles and pharmaceuticals despite short-term semiconductor challenges [112] Question: What is the expected full-year pricing benefit? - The company expects a full-year pricing benefit of around 2 points, slightly higher than previous guidance [104]